62
Views
2
CrossRef citations to date
0
Altmetric
Original Research

High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation

, , , , , , , , , , , & show all
Pages 635-640 | Received 30 Oct 2018, Accepted 13 May 2019, Published online: 20 May 2019

References

  • European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
  • Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13:e11–e22.
  • Verslype C, Rosmorduc O, Rougier P, ESMO Guidelines Working Group. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl.7):vii41–vii48.
  • Cescon M, Bertuzzo VR, Ercolani G, et al. Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol. 2013;19:9174–9182.
  • Bodzin AS, Busuttil RW. Hepatocellular carcinoma: advances in diagnosis, management, and long term outcome. World J Hepatol. 2015;7:1157–1167.
  • Toyoda H, Kumada T, Tada T, et al. Tumor markers for hepatocellular carcinoma: simple and significant predictors of outcome in patients with HCC. Liver Cancer. 2015;4:126–136.
  • Guerrero-Misas M, Rodríguez-Perálvarez M, de la Mata M. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol. 2015;7:649–661.
  • Slotta JE, Kollmar O, Ellenrieder V, et al. Hepatocellular carcinoma: surgeon’s view on latest findings and future perspectives. World J Hepatol. 2015;7:1168–1183.
  • Fischer U, Schulze-Osthoff K. Apoptosis-based therapies and drug targets. Cell Death Differ. 2005;12:942–961.
  • Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147:765–83.e4.
  • Canbay A, Feldstein A, Kronenberger B, et al. Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases. Z Gastroenterol. 2014;52:290–295.
  • Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18—the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther. 2009;30:1103–1109.
  • Lorente L, Martín MM, Pérez-Cejas A, et al. Sustained high serum caspase-3 concentrations and mortality in septic patients. Eur J Clin Microbiol Infect Dis. 2018;37:281–288.
  • Lorente L. Biomarkers associated with the outcome of traumatic brain injury patients. Brain Sci. 2017;7:pii:E142.
  • Balmer ML, Siegrist K, Zimmermann A, et al. Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. Liver Int. 2009;29:1184–1188.
  • Popov SS, Pashkov AN, Agarkov AA, et al. Intensity of apoptotic processes, aconitate hydratase activity and citrate level in patients with type 2 diabetes mellitus complicated steatohepatitis under application of epifamin at basic therapy. Biomed Khim. 2015;61:400–406.
  • Popov SS, Shulgin KK, Pashkov AN, et al. The effect of melaxen on the activity of caspases and the glutathione antioxidant system in toxic liver injury. Acta Naturae. 2014;6:110–118.
  • Tang W, Huang Z, Wang Y, et al. Effect of plasma exchange on hepatocyte oxidative stress, mitochondria function, and apoptosis in patients with acute fatty liver of pregnancy. Artif Organs. 2012;36:E39–E47.
  • Valva P, De Matteo E, Galoppo MC, et al. Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis. J Med Virol. 2010;82:949–957.
  • Bantel H, Lügering A, Poremba C, et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology. 2001;34:758–767.
  • Natori S, Rust C, Stadheim LM, et al. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol. 2001;34:248–253.
  • Fan M, Lu L, Su C, et al. Ultrasonic diagnosis of patients with clonorchiasis and preliminary study of pathogenic mechanism. Asian Pac J Trop Med. 2016;9:694–697.
  • Saich R, Selden C, Rees M, et al. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy. Artif Organs. 2007;31:732–742.
  • Lorente L, Rodriguez ST, Sanz P, et al. Prognostic value of serum caspase-cleaved cytokeratin-18 levels before liver transplantation for 1-year survival of patients with hepatocellular carcinoma. Int J Mol Sci. 2016;17:E1524.
  • Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
  • Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699.
  • Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.
  • Moya A, Berenguer M, Aguilera V, et al. Hepatocellular carcinoma: can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C? Liver Transpl. 2002;8:1020–1027.
  • Gelson W, Hoare M, Dawwas MF, et al. The pattern of late mortality in liver transplant recipients in the United Kingdom. Transplantation. 2011;91:1240–1244.
  • Shimod M, Ghobrial RM, Carmody IC, et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transpl. 2004;10:1478–1486.
  • Doyle MB, Vachharajani N, Maynard E, et al. Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes. J Am Coll Surg. 2012;215:19–28.
  • Martínez Ares D, Suárez López FJ, Souto Ruzo J, et al. Liver transplantation in patients with hepatocellular carcinoma: factors implicated in tumor relapse. Rev Esp Enferm Dig. 2004;96:22–31.
  • Dumitra S, Salleh I, Alabbad SI, et al. Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience. Hpb. 2013;15:724–731.
  • Teng F, Wang GH, Tao YF, et al. Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol. 2014;20:10900–10907.
  • Ninomiya M, Shirabe K, Facciuto ME, et al. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. J Am Coll Surg. 2015;220:297–304.
  • Varona MA, Del Pino JM, Barrera M, et al. Hepatocellular carcinoma and liver transplantation: a 12-year experience. Transplant Proc. 2009;41:1005–1008.
  • Varona MA, Soriano A, Aguirre-Jaime A, et al. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the α-fetoprotein model in a single-center experience. Transplant Proc. 2015;47:84–89.
  • Stahl JE, Kreke JE, Malek FA, et al. Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS One. 2008;3:e2468.
  • Morris KL, Tugwood JD, Khoja L, et al. Circulating biomarkers in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2014;74:323–332.
  • Lorente L. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World J Gastroenterol. 2018;24:4230–4242.
  • Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–439.
  • Caulín C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol. 1997;138:1379–1394.
  • Lorente L, Martín MM, Argueso M, et al. Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury. BMC Neurol. 2015;15:228.
  • Lorente L, Martín MM, Ferreres J, et al. Serum caspase 3 levels are associated with early mortality in severe septic patients. J Crit Care. 2016;34:103–106.
  • Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 2014;5:e996.
  • Zhou L, Rui JA, Zhou WX, et al. Edmondson-Steiner grade: a crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasion. Pathol Res Pract. 2017;213:824–830.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.